Published in N Engl J Med on February 05, 2009
Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med (2013) 15.85
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
A de novo paradigm for mental retardation. Nat Genet (2010) 8.57
Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature (2011) 4.85
De novo mutations in human genetic disease. Nat Rev Genet (2012) 3.81
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet (2013) 3.64
Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet (2011) 2.86
Next-generation genetic testing for retinitis pigmentosa. Hum Mutat (2012) 2.30
A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci (2013) 2.24
Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet (2012) 2.12
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. Hum Mol Genet (2011) 1.70
Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun (2014) 1.59
A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am J Hum Genet (2009) 1.55
Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci Transl Med (2014) 1.55
The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord (2010) 1.45
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell (2012) 1.42
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry (2011) 1.40
Genetic studies in intellectual disability and related disorders. Nat Rev Genet (2015) 1.40
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS One (2012) 1.14
On the future of genetic risk assessment. J Community Genet (2012) 1.12
Deletion of densin-180 results in abnormal behaviors associated with mental illness and reduces mGluR5 and DISC1 in the postsynaptic density fraction. J Neurosci (2011) 1.07
Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nat Commun (2017) 1.07
A novel mutation in the DLG3 gene encoding the synapse-associated protein 102 (SAP102) causes non-syndromic mental retardation. Neurogenetics (2009) 1.04
Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis. Sci Signal (2013) 1.03
Rapid dispersion of SynGAP from synaptic spines triggers AMPA receptor insertion and spine enlargement during LTP. Neuron (2015) 0.98
Regulation of synapse structure and function by distinct myosin II motors. J Neurosci (2011) 0.96
SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity. J Neurosci (2013) 0.90
Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. Front Genet (2012) 0.89
Expression of non-protein-coding antisense RNAs in genomic regions related to autism spectrum disorders. Mol Autism (2013) 0.88
De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome. Cell Res (2014) 0.87
Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons. Neuron (2014) 0.87
Mechanistic basis of MAGUK-organized complexes in synaptic development and signalling. Nat Rev Neurosci (2016) 0.87
Modulation of behavior by scaffolding proteins of the post-synaptic density. Neurobiol Learn Mem (2013) 0.86
SYNGAP1: Mind the Gap. Front Cell Neurosci (2016) 0.84
De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention. Genome Med (2012) 0.83
Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? Mol Autism (2013) 0.83
De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability. Am J Med Genet A (2015) 0.83
SynGAP regulates protein synthesis and homeostatic synaptic plasticity in developing cortical networks. PLoS One (2013) 0.82
Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia. Front Cell Neurosci (2015) 0.81
Convergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/y Mice. J Neurosci (2015) 0.81
Integrated analysis of clinical signs and literature data for the diagnosis and therapy of a previously undescribed 6p21.3 deletion syndrome. Eur J Hum Genet (2010) 0.81
Discontinuity in the genetic and environmental causes of the intellectual disability spectrum. Proc Natl Acad Sci U S A (2015) 0.80
Genome-Wide Association Studies Suggest Limited Immune Gene Enrichment in Schizophrenia Compared to 5 Autoimmune Diseases. Schizophr Bull (2016) 0.79
Triggers for autism: genetic and environmental factors. J Cent Nerv Syst Dis (2012) 0.78
Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins. ISRN Oncol (2013) 0.78
SYNGAP: bridging the gap between genetic factors and autosomal non-syndromic mental retardation. Clin Genet (2009) 0.78
Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis. Hum Mol Genet (2015) 0.77
Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly. Biol Psychiatry (2014) 0.77
Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies. Neural Plast (2016) 0.77
Convergent synaptic and circuit substrates underlying autism genetic risks. Front Biol (Beijing) (2014) 0.77
Prioritizing the development of mouse models for childhood brain disorders. Neuropharmacology (2015) 0.76
Homozygous deletion of Tenascin-R in a patient with intellectual disability. J Med Genet (2012) 0.76
A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions. PLoS One (2016) 0.75
Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability. J Hum Genet (2015) 0.75
Increased Excitatory Synaptic Transmission of Dentate Granule Neurons in Mice Lacking PSD-95-Interacting Adhesion Molecule Neph2/Kirrel3 during the Early Postnatal Period. Front Mol Neurosci (2017) 0.75
Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function. Nat Commun (2016) 0.75
Missense variants in AIMP1 gene are implicated in autosomal recessive intellectual disability without neurodegeneration. Eur J Hum Genet (2015) 0.75
mirDNMR: a gene-centered database of background de novo mutation rates in human. Nucleic Acids Res (2016) 0.75
Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet (2017) 0.75
Expansion of the RASopathies. Curr Genet Med Rep (2016) 0.75
Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. Sci Rep (2017) 0.75
Synaptic Interactome Mining Reveals p140Cap as a New Hub for PSD Proteins Involved in Psychiatric and Neurological Disorders. Front Mol Neurosci (2017) 0.75
Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report. BMC Med Genet (2017) 0.75
The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol (2007) 6.91
PTC124 targets genetic disorders caused by nonsense mutations. Nature (2007) 6.67
The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet (2000) 6.44
Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet (2006) 3.80
Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron (2005) 3.72
X-linked mental retardation. Nat Rev Genet (2005) 3.10
SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron (1998) 2.63
Genetics and pathophysiology of mental retardation. Eur J Hum Genet (2006) 2.52
SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci (2002) 2.46
Dendritic spine "dysgenesis" and mental retardation. Science (1974) 2.44
A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. Am J Hum Genet (2008) 2.18
A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. Am J Hum Genet (2007) 2.13
SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci U S A (2006) 2.11
SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron (2004) 1.97
Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet (2008) 1.82
NMDA receptors and schizophrenia. Curr Opin Pharmacol (2006) 1.73
The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J Neurosci (2003) 1.71
The role of neuronal complexes in human X-linked brain diseases. Am J Hum Genet (2007) 1.71
SynGAP regulates spine formation. J Neurosci (2004) 1.51
Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci (2004) 1.45
The C2 domain of SynGAP is essential for stimulation of the Rap GTPase reaction. EMBO Rep (2008) 1.31
Genetics of autosomal recessive non-syndromic mental retardation: recent advances. Clin Genet (2007) 1.13
Characterization of a novel synGAP isoform, synGAP-beta. J Biol Chem (2001) 1.09
Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem (2005) 1.06
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet (2008) 9.51
Variation in genome-wide mutation rates within and between human families. Nat Genet (2011) 8.84
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity (2008) 7.60
Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci (2008) 7.14
Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry (2008) 6.78
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry (2011) 5.85
Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry (2005) 5.52
Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA (2002) 4.72
Global prevalence of autism and other pervasive developmental disorders. Autism Res (2012) 4.62
G protein-coupled receptor-dependent development of human frontal cortex. Science (2004) 4.42
Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage (2004) 4.13
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Hyperspectral remote sensing of foliar nitrogen content. Proc Natl Acad Sci U S A (2012) 3.87
Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry (2002) 3.84
Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron (2010) 3.74
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Mutations in VANGL1 associated with neural-tube defects. N Engl J Med (2007) 3.58
The prevalence of autism. JAMA (2003) 3.57
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med (2009) 3.32
Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol (2007) 3.19
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology (2002) 3.02
A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry (2011) 2.99
Previously suicidal adolescents: predictors of six-month outcome. J Can Acad Child Adolesc Psychiatry (2008) 2.98
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet (2006) 2.92
Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch Neurol (2007) 2.89
Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet (2011) 2.86
Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol (2011) 2.83
Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol (2007) 2.76
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci (2007) 2.75
Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet (2002) 2.72
Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol (2013) 2.69
Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet (2003) 2.58
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet (2009) 2.40
The level and nature of autistic intelligence. Psychol Sci (2007) 2.35
Chinese physicians and their smoking knowledge, attitudes, and practices. Am J Prev Med (2007) 2.32
Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet (2009) 2.31